Market Cap 1.14B
Revenue (ttm) 168.63M
Net Income (ttm) 16.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 9.77%
Debt to Equity Ratio 0.00
Volume 1,121,700
Avg Vol 803,592
Day's Range N/A - N/A
Shares Out 121.55M
Stochastic %K 94%
Beta 1.22
Analysts Strong Sell
Price Target $15.38

Company Profile

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as TCR-engineered autologous or allogeneic adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid t...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 7071 5397 0
Fax: 49 7071 5397 900
Address:
Paul-Ehrlich-Strasse 15, Tübingen, Germany
RunnerSignals
RunnerSignals Oct. 3 at 8:27 PM
Market Warriors Rise 💥 From red to green $RKLB $ARBE $HOUS $HUM $IMTX showed the fighting spirit today!
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 2 at 1:49 PM
$IMTX Excellent article that nails exactly where IMTX stands right now. So if you want to update your IMTX knowledge or get acquainted with IMTX, this is a must read. https://beyondspx.com/quote/IMTX/analysis/immatics-precision-oncology-unlocking-solid-tumor-potential-with-tcr-engineered-therapies-nasdaq-imtx
2 · Reply
RamenLives
RamenLives Oct. 1 at 5:35 PM
$IMTX Just curious, if a BO happens, what is a reasonable expectation of share price? IMO $30 seem about right.
2 · Reply
RemoteInvestor
RemoteInvestor Oct. 1 at 5:12 PM
$IMTX https://investors.immatics.com/news-releases/news-release-details/immatics-appoints-venkat-ramanan-chief-financial-officer
0 · Reply
dgbio
dgbio Oct. 1 at 5:05 PM
$IMTX New CFO with a deal-making background. Interesting
3 · Reply
RemoteInvestor
RemoteInvestor Oct. 1 at 12:20 PM
$IMTX want to add more today but it is already rising pre-market...
1 · Reply
NJgolfer
NJgolfer Sep. 30 at 8:34 PM
$IMTX this highlight in March 2025 was spot on and since that time $IMTX has exceeded my expectations. Still think by end of 2026, this is multiple times higher from here.
1 · Reply
RemoteInvestor
RemoteInvestor Sep. 30 at 5:26 PM
$IMTX great volume and rising!
0 · Reply
RemoteInvestor
RemoteInvestor Sep. 30 at 1:40 PM
Combining $IMTX T-Cell approach with $MRNA technology - cooperation still alive?
1 · Reply
RemoteInvestor
RemoteInvestor Sep. 29 at 6:49 PM
$IMTX just added. This is a 'once in a lifetime' opportunity! Revolutionary cancer treatment!
0 · Reply
Latest News on IMTX
Immatics N.V.: Trading Below Cash, But Not Without Reason

Mar 28, 2025, 1:02 PM EDT - 6 months ago

Immatics N.V.: Trading Below Cash, But Not Without Reason


Immatics: A Promising TCR Pipeline

Oct 11, 2024, 9:11 PM EDT - 1 year ago

Immatics: A Promising TCR Pipeline


Immatics Announces Pricing of $150 Million Public Offering

Oct 10, 2024, 8:50 PM EDT - 1 year ago

Immatics Announces Pricing of $150 Million Public Offering


Immatics Announces Proposed $150 Million Public Offering

Oct 10, 2024, 7:30 AM EDT - 1 year ago

Immatics Announces Proposed $150 Million Public Offering


Immatics Announces Pricing of $175 Million Public Offering

Jan 17, 2024, 8:30 PM EST - 1 year ago

Immatics Announces Pricing of $175 Million Public Offering


Immatics Announces Proposed Public Offering

Jan 17, 2024, 4:01 PM EST - 1 year ago

Immatics Announces Proposed Public Offering


Analyzing Immatics' Multi-Faceted Investment Case

Oct 9, 2023, 1:33 AM EDT - 2 years ago

Analyzing Immatics' Multi-Faceted Investment Case


Immatics shares rise on Moderna cancer collaboration

Sep 11, 2023, 8:59 AM EDT - 2 years ago

Immatics shares rise on Moderna cancer collaboration

MRNA


Moderna, Immatics to work jointly on cancer vaccines

Sep 11, 2023, 7:32 AM EDT - 2 years ago

Moderna, Immatics to work jointly on cancer vaccines

MRNA


Immatics Is Increasingly Becoming Interesting

Jul 24, 2023, 10:00 AM EDT - 2 years ago

Immatics Is Increasingly Becoming Interesting


Why you should consider buying and accumulating Immatics N.V.

Jun 3, 2022, 6:28 PM EDT - 3 years ago

Why you should consider buying and accumulating Immatics N.V.


RunnerSignals
RunnerSignals Oct. 3 at 8:27 PM
Market Warriors Rise 💥 From red to green $RKLB $ARBE $HOUS $HUM $IMTX showed the fighting spirit today!
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 2 at 1:49 PM
$IMTX Excellent article that nails exactly where IMTX stands right now. So if you want to update your IMTX knowledge or get acquainted with IMTX, this is a must read. https://beyondspx.com/quote/IMTX/analysis/immatics-precision-oncology-unlocking-solid-tumor-potential-with-tcr-engineered-therapies-nasdaq-imtx
2 · Reply
RamenLives
RamenLives Oct. 1 at 5:35 PM
$IMTX Just curious, if a BO happens, what is a reasonable expectation of share price? IMO $30 seem about right.
2 · Reply
RemoteInvestor
RemoteInvestor Oct. 1 at 5:12 PM
$IMTX https://investors.immatics.com/news-releases/news-release-details/immatics-appoints-venkat-ramanan-chief-financial-officer
0 · Reply
dgbio
dgbio Oct. 1 at 5:05 PM
$IMTX New CFO with a deal-making background. Interesting
3 · Reply
RemoteInvestor
RemoteInvestor Oct. 1 at 12:20 PM
$IMTX want to add more today but it is already rising pre-market...
1 · Reply
NJgolfer
NJgolfer Sep. 30 at 8:34 PM
$IMTX this highlight in March 2025 was spot on and since that time $IMTX has exceeded my expectations. Still think by end of 2026, this is multiple times higher from here.
1 · Reply
RemoteInvestor
RemoteInvestor Sep. 30 at 5:26 PM
$IMTX great volume and rising!
0 · Reply
RemoteInvestor
RemoteInvestor Sep. 30 at 1:40 PM
Combining $IMTX T-Cell approach with $MRNA technology - cooperation still alive?
1 · Reply
RemoteInvestor
RemoteInvestor Sep. 29 at 6:49 PM
$IMTX just added. This is a 'once in a lifetime' opportunity! Revolutionary cancer treatment!
0 · Reply
RemoteInvestor
RemoteInvestor Sep. 25 at 3:31 PM
$IMTX some background on PRAME https://en.m.wikipedia.org/wiki/PRAME#
0 · Reply
RemoteInvestor
RemoteInvestor Sep. 25 at 2:50 PM
$IMTX now is the time to accumulate. Just did it! Completely uncorrelated to $VTGN therefore perfect hedge!
1 · Reply
S_Franconi
S_Franconi Sep. 24 at 8:29 PM
$IMTX Nice.
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 19 at 12:06 AM
$IMTX WOODLINE PARTNERS BUYS A 7.6 MILLION DOLLAR STAKE IN $IMTX
1 · Reply
JarvisFlow
JarvisFlow Sep. 18 at 1:04 PM
Guggenheim has adjusted their stance on Immatics ( $IMTX ), setting the rating to Buy with a target price of 16.
1 · Reply
Quantumup
Quantumup Sep. 16 at 3:31 PM
H.C. Wainwright reiterated $IMCR Buy/$100 after hosting $IMCR's Mgmt Sept. 8, at its well-attended 27th Annual Global Investment Conference. H.C. Wainwright said: Management was upbeat on the robust KIMMTRAK revenue growth seen in 1H25, which continues to support the pipeline expansion, including in autoimmune programs. With a cash position of $883 million as of June 30, 2025, and a maturing clinical pipeline across multiple therapeutic areas, we believe Immunocore is well positioned for continued growth. We reiterate our Buy rating and $100 price target on $IMCR. $BMY $MRK $DCTH $IMTX
0 · Reply
ccranfi1956
ccranfi1956 Sep. 8 at 3:47 PM
$IMTX bipolar😂😒
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Sep. 5 at 4:35 PM
$IMTX 20/50 MA breakout
1 · Reply
estatebuyersmia
estatebuyersmia Sep. 5 at 3:28 PM
$IMTX LOOK AT $IMTX GO...
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 3 at 8:28 PM
$IMTX added at close....
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 3 at 12:20 PM
$FBIO CHATGPT TOLD ME TO BUY $FBIO AND $IMTX yesterday morning and look at them go....
0 · Reply
estatebuyersmia
estatebuyersmia Sep. 2 at 9:03 PM
$IMTX Chatgpt told me to buy this stock today so I did....
1 · Reply